115 related articles for article (PubMed ID: 29415082)
21. Phosphoinositide signaling in cancer: INPP4B Akt(s) out.
Woolley JF; Dzneladze I; Salmena L
Trends Mol Med; 2015 Sep; 21(9):530-2. PubMed ID: 26150301
[TBL] [Abstract][Full Text] [Related]
22. Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.
Xie BH; He X; Hua RX; Zhang B; Tan GS; Xiong SQ; Liu LS; Chen W; Yang JY; Wang XN; Li HP
Cancer Biomark; 2016; 16(3):405-13. PubMed ID: 27062697
[TBL] [Abstract][Full Text] [Related]
23. Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML.
Cuenco GM; Nucifora G; Ren R
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1760-5. PubMed ID: 10677531
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and biological characteristics of childhood acute myeloid leukemia with EVI1 gene positive expression].
Jiang M; Li XQ; Hu D; Qiu YN; Zhang ZQ; Zhang BY; Han J; Jin RM
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):129-34. PubMed ID: 24568904
[TBL] [Abstract][Full Text] [Related]
25. INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.
Chi MN; Guo ST; Wilmott JS; Guo XY; Yan XG; Wang CY; Liu XY; Jin L; Tseng HY; Liu T; Croft A; Hondermarck H; Scolyer RA; Jiang CC; Zhang XD
Oncotarget; 2015 Nov; 6(37):39891-907. PubMed ID: 26573229
[TBL] [Abstract][Full Text] [Related]
26. Review: Aberrant EVI1 expression in acute myeloid leukaemia.
Hinai AA; Valk PJ
Br J Haematol; 2016 Mar; 172(6):870-8. PubMed ID: 26729571
[TBL] [Abstract][Full Text] [Related]
27. INPP4B overexpression suppresses migration, invasion and angiogenesis of human prostate cancer cells.
Chen H; Li H; Chen Q
Clin Exp Pharmacol Physiol; 2017 Jun; 44(6):700-708. PubMed ID: 28261855
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of Inositol Polyphosphate 4-Phosphatase Type II Expression in Colorectal Carcinoma.
Sung JY; Na K; Kim HS
Anticancer Res; 2017 Oct; 37(10):5525-5531. PubMed ID: 28982866
[TBL] [Abstract][Full Text] [Related]
29. EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.
Balgobind BV; Lugthart S; Hollink IH; Arentsen-Peters ST; van Wering ER; de Graaf SS; Reinhardt D; Creutzig U; Kaspers GJ; de Bont ES; Stary J; Trka J; Zimmermann M; Beverloo HB; Pieters R; Delwel R; Zwaan CM; van den Heuvel-Eibrink MM
Leukemia; 2010 May; 24(5):942-9. PubMed ID: 20357826
[TBL] [Abstract][Full Text] [Related]
30. INPP4B reverses docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer.
Chen H; Li H; Chen Q
Biochem Biophys Res Commun; 2016 Aug; 477(3):467-72. PubMed ID: 27318090
[TBL] [Abstract][Full Text] [Related]
31. Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.
Asleh-Aburaya K; Sheffield BS; Kos Z; Won JR; Wang XQ; Gao D; Wolber R; Gilks CB; Bernard PS; Chia SK; Nielsen TO
Histopathology; 2017 Jan; 70(2):185-194. PubMed ID: 27402148
[TBL] [Abstract][Full Text] [Related]
32. High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML.
Jo A; Mitani S; Shiba N; Hayashi Y; Hara Y; Takahashi H; Tsukimoto I; Tawa A; Horibe K; Tomizawa D; Taga T; Adachi S; Yoshida T; Ichikawa H
Leukemia; 2015 May; 29(5):1076-83. PubMed ID: 25567132
[TBL] [Abstract][Full Text] [Related]
33. Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3.
Ding H; Sun Y; Hou Y; Li L
Urol Oncol; 2014 Jul; 32(5):720-6. PubMed ID: 24837011
[TBL] [Abstract][Full Text] [Related]
34. Functional identification of a novel transcript variant of INPP4B in human colon and breast cancer cells.
Croft A; Guo ST; Sherwin S; Farrelly M; Yan XG; Zhang XD; Jiang CC
Biochem Biophys Res Commun; 2017 Mar; 485(1):47-53. PubMed ID: 28189677
[TBL] [Abstract][Full Text] [Related]
35. INPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival.
Rynkiewicz NK; Fedele CG; Chiam K; Gupta R; Kench JG; Ooms LM; McLean CA; Giles GG; Horvath LG; Mitchell CA
Prostate; 2015 Jan; 75(1):92-102. PubMed ID: 25284366
[TBL] [Abstract][Full Text] [Related]
36. INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells.
Min JW; Kim KI; Kim HA; Kim EK; Noh WC; Jeon HB; Cho DH; Oh JS; Park IC; Hwang SG; Kim JS
Biochem Biophys Res Commun; 2013 Oct; 440(1):137-42. PubMed ID: 24051093
[TBL] [Abstract][Full Text] [Related]
37. Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia.
Abramowitz J; Neuman T; Perlman R; Ben-Yehuda D
BMC Med Genomics; 2017 Mar; 10(1):18. PubMed ID: 28340577
[TBL] [Abstract][Full Text] [Related]
38. Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia.
Luo H; Qin Y; Reu F; Ye S; Dai Y; Huang J; Wang F; Zhang D; Pan L; Zhu H; Wu Y; Niu T; Xiao Z; Zheng Y; Liu T
J Hematol Oncol; 2016 Nov; 9(1):125. PubMed ID: 27855695
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of using the combined MDS-EVI1/EVI1 gene expression as an alternative molecular marker in acute myeloid leukemia: a report of four cases.
Weisser M; Haferlach C; Haferlach T; Schnittger S
Cancer Genet Cytogenet; 2007 Aug; 177(1):64-9. PubMed ID: 17693194
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes.
Thol F; Yun H; Sonntag AK; Damm F; Weissinger EM; Krauter J; Wagner K; Morgan M; Wichmann M; Göhring G; Bug G; Ottmann O; Hofmann WK; Schambach A; Schlegelberger B; Haferlach T; Bowen D; Mills K; Ganser A; Heuser M
Ann Hematol; 2012 Aug; 91(8):1221-33. PubMed ID: 22488406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
